Robin Hume
Robin has more than 20 years of deep scientific, strategic and operational experience in the biopharmaceutical industry including early and late-stage drug development and commercialization. Robin is recognized as a forward thinker in R&D strategy, identifying and incorporating innovative regulatory strategies to rapidly advance new drug and biologic product development to approval in the US and globally. She has a passion for building and leading high performing product teams focused on the discovery, development and commercialization of new drugs and biologics and empowering teams to navigate, problem solve and bring high impact new medicines to patients with unmet needs.
Robin has success in regulatory leadership, bringing products from development to approval, initially with Gentium S.p.A, which was later acquired by Jazz Pharmaceuticals, and within Jazz Pharmaceuticals where she held various leadership roles to successfully advance three products through the regulatory approval process.